APA (7th ed.) Citation

Gurau, A., Yamauchi, S., Ecoff, K., Rodgers, K. P., Eshleman, J. R., Jr, C. C. T., . . . Mei, Y. PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapy. KeAi Communications Co., Ltd.

Chicago Style (17th ed.) Citation

Gurau, Andrei, et al. PD-L1 PfeRNAs as Blood-based Predictors of Treatment Response of Unresectable Malignant Pleural Mesothelioma Patients Administered Durvalumab with Cisplatin and Pemetrexed as First-line Therapy. KeAi Communications Co., Ltd.

MLA (9th ed.) Citation

Gurau, Andrei, et al. PD-L1 PfeRNAs as Blood-based Predictors of Treatment Response of Unresectable Malignant Pleural Mesothelioma Patients Administered Durvalumab with Cisplatin and Pemetrexed as First-line Therapy. KeAi Communications Co., Ltd.